Azenta Life Sciences

Company Deals

Azenta Life Sciences and Vazyme Biotech Form Global Partnership for Comprehensive Services

Fineline Cube May 23, 2023

Azenta Life Sciences (NASDAQ: AZTA) has entered into a global partnership with China-based Vazyme Biotech...

Company Drug

Yizun Biomedicine’s CNK-UT Cell Therapy Initiates Patient Enrollment for Solid Tumor Trial

Fineline Cube May 17, 2023

Hangzhou-based cell therapy specialist Yizun Biomedicine Co., Ltd has announced the completion of first patient...

Company Deals

ST Phi Therapeutics Partners with Azenta Life Sciences to Advance Cell Therapy

Fineline Cube Dec 6, 2022

Hangzhou-based cell therapy specialist ST Phi Therapeutics struck a partnership with US firm Azenta Life...

Company Drug

InnoCare’s Zurletrectinib Wins NMPA Nod as China’s First Next-Gen TRK Inhibitor

Company Deals

Brii Biosciences Taps OpenBench AI Platform to Accelerate Drug Discovery

Company Deals

GSK Terminates Ideaya Synthetic Lethality Partnership, Returns Two Clinical Programs

Company Deals

B&K Corporation Debuts on HKEX in $900M IPO Backed by Burn Drug Pipeline